Several enzymes in NAD metabolic pathway such as nicotinamide phosphoribosyl transferase (NAMPT), NAD + kinase, and the NAD-dependent sirtuin family have been reported to be altered in pancreatic cancer. This evidence concerns the gene NADK and familial pancreatic carcinoma.